Search Login Register
pamidronate
(APD)
Summary
Description:
inhibits osteolytic bone lesions; inhibits the mevalonate pathway, which is required for the prenylation of the small GTPase; RN given refers to parent cpd
Also Known As:
APD; Aredia; (3-amino-1-hydroxypropylidene)-1,1-biphosphonate; (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate; 1-hydroxy-3-aminopropane-1,1-diphosphonic acid Show All >>
Networked: 2567
relevant articles (284 outcomes,
459 trials/studies)
for this Drug
Key Diseases for which pamidronate is
Relevant
-
Pain (Aches)
:
56 outcomes 33 studies in 200 results
-
Hypercalcemia (Milk Alkali Syndrome)
:
39 outcomes 19 studies in 204 results
-
Neoplasm Metastasis (Metastasis)
:
31 outcomes 61 studies in 219 results
-
Breast Neoplasms (Breast Cancer)
:
28 outcomes 67 studies in 183 results
-
Osteoporosis
:
22 outcomes 31 studies in 136 results
Show All >>
Drugs Related to pamidronate
-
pamidronate (APD)
-
zoledronic acid (zoledronate)
-
Diphosphonates
-
Clodronic Acid (Clodronate)
-
Calcium
-
Calcitonin (Calcitonin, Eel)
-
Vitamin D
-
Alkaline Phosphatase
-
Alendronate (Alendronate Sodium)
-
ibandronic acid (Boniva)
Show All >>
Therapies Related to pamidronate
-
Intravenous Infusions
-
Drug Therapy (Chemotherapy)
-
Continuous Ambulatory Peritoneal Dialysis (CAPD)
-
Transplants (Transplant)
-
Radiotherapy
Show All >>
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.